Board of Directors

 

Rx&D has an effective and engaged Board of Directors that enables member companies to achieve common objectives.

Executive Committee/Officers

Chair
John Helou, President, Pfizer Canada Inc.
First Vice-Chair
Michael Tremblay, President, Astellas Pharma Canada, Inc.
Second Vice Chair
Frédéric Fasano, Chief Executive Officer, Servier Canada Inc.
Treasurer
Vince Lamanna, President, Novo Nordisk
Canada Inc.
Member at Large
Paul Lirette, President, GlaxoSmithKline Inc. 
Immediate Past Chair
Mark Lievonen, President, Sanofi Pasteur Limited
Ex-Officio
Chris Halyk, President, Janssen Inc.
Ex-OfficioRonnie Miller, President & CEO, Hoffmann-La Roche Limited 
President Russell Williams, Canada’s Research-Based Pharmaceutical Companies (Rx&D)

Directors

Mark Beaudet, President & CEO, Paladin Labs Inc.

Patrick Cashman, President and General Manager, Lundbeck Canada Inc.

Mike Egli, President & CEO, Takeda Canada Inc.

Gilles Gagnon, President & CEO, Ceapro Inc.

Ed Gudaitis, General Manager, Gilead Sciences Canada Inc.

Chirfi Guindo, President & Managing Director, Merck Canada Inc.

Helen Jordan, General Manager and Vice-President, Amgen Canada Inc.

Craig Landau, President and CEO, Purdue Pharma

Stéphane Lassignardie, General Manager, AbbVie Corporation 

Christian Lauterbach, President & CEO, Bayer Inc.

Jean-François Leprince, President, GLyPharma Therapeutique Inc.  

Tim Maloney, President, Novartis Pharmaceuticals Canada Inc.

Lisa Matar, President & General Manager, Eli Lilly Canada inc.

Dr. Nawal Peacock, President & General Manager, Bristol-Myers Squibb Canada 

Allison Rosental, General Manager, Otsuka Canada Pharmaceutical Inc. (OCPI)

Oliver Technow, President & General Manager, Eisai Limited

Revised: January 27, 2015